High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver
- 1 April 1987
- journal article
- research article
- Published by Elsevier BV in Analytical Biochemistry
- Vol. 162 (1), 24-32
- https://doi.org/10.1016/0003-2697(87)90006-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizersBiochemical and Biophysical Research Communications, 1984
- Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylationFEBS Letters, 1984
- Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine-type polymorphism of drug oxidationEuropean Journal of Clinical Investigation, 1984
- A rapid method for removal of detergents from protein solutionAnalytical Biochemistry, 1983
- Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.British Journal of Clinical Pharmacology, 1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964